Zacks: we have a PT of $30 https://scr.zacks.com/News/Press-Releases/Press-Release-Details/2020/CFRX-Interim-Futility-Analysis-for-Phase-3-DISRUPT-Trial-Once-60-Enrolled-article/default.aspx